Fundraising Fox

Relay Therapeutics

NASDAQ: RLAY

Cambridge, US · Founded 2016 · Delaware corporation · 223 employees on LinkedIn · 3 known investors

Improving patients' lives by accelerating development and commercialization of medicines that matter.

Biotech

Founders & leadership

SK
Sanjiv K. PatelinExecutive
DA
Donald A. BergstrominExecutive
TC
Thomas CatinazzoNamed on SEC filing
PR
Peter RahmerNamed on SEC filing
SK
Sekar KathiresanNamed on SEC filing
DS
Douglas S. IngramNamed on SEC filing
MM
Mark MurckoNamed on SEC filing
LS
Laura ShawverNamed on SEC filing
BA
Brian AdamsNamed on SEC filing
LH
Linda HillNamed on SEC filing
JR
Jami RubinNamed on SEC filing

Board

AB
Alexis BorisyBoard director

Investors · 3

Commonweal VenturesNew York · $500K – $2.5M
Foresite CapitalWest Hollywood
Curie.BioreportedCambridge · $7M

Reported raises · per SEC filings

Form D private placements

$30M disclosed across 1 round · 2024

▶$30MraisedJan 2024 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas CatinazzoExecutive Officer
  • Peter RahmerExecutive Officer
  • Sekar KathiresanDirector
  • Douglas S. IngramDirector
  • Sanjiv K. PatelExecutive Officer, Director
  • Mark MurckoDirector
  • Laura ShawverDirector
  • Brian AdamsExecutive Officer
  • Linda HillDirector
  • Jami RubinDirector
  • Donald A. BergstromExecutive Officer
  • Alexis BorisyDirector
Offering amount
$30M
Amount sold
$30M
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Relay Therapeutics (RLAY) Reported Q2 Results, Is The Premium P B Multiple Justified?finance.yahoo.com · Aug 2026H.C. Wainwright raises Relay Therapeutics price target to $29 By Investing.cominvesting.com · Aug 2026Relay Therapeutics (RLAY) Stock May Be Fully Valued After A 7x Run - Simply Wall St Newssimplywall.st · Aug 2026Persistent Asset Partners Ltd Makes New $1.32 Million Investment in Relay Therapeutics, Inc. $RLAYmarketbeat.com · Aug 2026Citizens raises Relay Therapeutics stock price target on progress By Investing.comm.in.investing.com · Aug 2026Relay Therapeutics, Inc. (RLAY): Investor Outlook On A Biotech With 33% Potential Upsidedirectorstalkinterviews.com · Aug 2026

Frequently asked questions

What does Relay Therapeutics do?
Improving patients' lives by accelerating development and commercialization of medicines that matter.
Who are Relay Therapeutics's investors?
Relay Therapeutics's investors include Commonweal Ventures, Foresite Capital, Curie.Bio.
How much funding has Relay Therapeutics raised?
Relay Therapeutics has disclosed $30M raised across 1 round.
Where is Relay Therapeutics headquartered?
Relay Therapeutics is headquartered in Cambridge, US.